Acute hemodynamic changes during far infrared treatment of the arteriovenous fistula in hemodialysis patients

September 1, 2023

Abstract

Background: The arteriovenous fistula (AVF) is the preferred vascular access for hemodialysis (HD) treatment and

preservation of a stable vascular access is crucial. Long term Far Infrared Radiation (FIR) has been found to increase

access flow together with an enhanced maturation and patency of the AVF. The acute effects of FIR on access flow have

been sparsely described and the results are contradictory, perhaps due to differences in measurement conditions and

other factors of importance for access flow.

Methods: Twenty patients in HD with an AVF were included. Each patient was randomized to receive either FIR

(FIR group) or no FIR (control group). The acute changes in access flow were investigated in both groups on the

second dialysis day of the week and during the first 1.5 h of the dialysis session. Concomitant changes in hemodynamic

parameters of importance for access flow were also explored.

Results: There was no significant change in access flow in the FIR group compared with the control group (median

(Interquartile Range)) (−10 (−413.8; 21.3) ml/min vs −17.5 (−83.8; 76.3) ml/min, p = 0.58). There was no significant

difference in any of the hemodynamic parameters between the FIR and the control group; cardiac output (−0.7 (−1.2;

−0.2) l/min vs −0.4 (−0.9; 0.1) l/min, p = 0.58), cardiac index (−0.3 (−0.5; −0.1)) l/min/m2 vs −0.3 (−0.4; 0) l/min/m2, p = 0.68),

mean arterial pressure (5.5 (−1.8; 8.4) mmHg vs 1.5 (−3; 6.3) mmHg, p = 0.35) and total peripheral resistance (2 (1.8; 3.4)

mmHg × min/l vs 1 (−0.3; 3.1) mmHg × min/l, p = 0.12).

Conclusion: In this trial, with a highly standardized set-up, one session of FIR did not result in any acute changes in

access flow. This was not due to differences in the hemodynamic parameters between the groups.

-J Vasc Access. 2023 Jul;24(4):739-746.

Want to know more?



Contact us for more detail


Learn more
Questions to FIRAPY
August 19, 2026
A new study published in Cells has provided further insight into the molecular responses of arterial endothelial cells following far-infrared (FIR) irradiation.  The study, conducted by researchers from Gunma Paz University, Japan, investigated the effects of FIR on human femoral artery endothelial cells (HFAECs) using an integrated multi-omics approach combining transcriptomics, proteomics, and phosphoproteomics. FIR irradiation was delivered using the WSTM TY101F far-infrared therapy unit manufactured by WS Far Infrared Medical Technology.
FIRAPY at MEDICA 2026 | Innovative Care for Dialysis Patients
August 19, 2026
Meet FIRAPY at MEDICA 2026 in Düsseldorf, November 16–19. Visit Hall 16, Booth B03-2 to explore innovative far infrared therapy for dialysis patient care.
More Posts